11. Easton J., Noble S., Perry C.M. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media // Drugs. – 2003. – Vol. 63, N 3. – P. 311–340.
12. Fokkens W.J., Lund V.J., Mullol J. et al. European Position Paper on Nasal Polyps 2007 // Rhinology. – 2007. – Vol. 45 (Suppl. 20). – P. 1–139.
13. Внебольничная пневмония у детей: распространенность, диагностика, лечение, профилактика. Научно–практическая программа – М.: Оригинал–макет, 2011 – 64 с.
14. Bansal A., Singhi S.C., Jayashree M. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia // Indian. J. Pediatr. – 2006. – Vol. 73, N 4. – P. 305–309.
15. Ribeiro C.F., Ferrari G.F., Fioretto J.R. Antibiotic treatment schemes for very severe community–acquired pneumonia in children: a randomized clinical study // Rev. Panam. Salud. Publica. – 2011. – Vol. 29, N 6. – P. 444– 450.
16. Rosenbulut A., Santolaya M.E., Gonzalez P. et al. Penicillin resistance is not extrapolable to amoxicillin resistance in Streptococcus pneumonia isolated from middle ear fluid in children with acute otitis media //Ann. Otol. Rhinol. Laryngol. – 2006. – Vol. 115, N 3. – P. 186–190.
17. Jacobs M.R., Felmingham D., Appelbaum P.C. et al. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community–acquired respiratory tract infection to commonly used antimicrobial agents // J. Antimicrob. Chemother. – 2003. – Vol. 52, N 2. – P. 229–246.
18. Козлов Р.С., Сивая О.В., Кречикова О.И. и др. Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999–2009 гг. // Клин. микробиол. антимикроб. химиотер. – 2010. –Т. 12(4).– С. 329–341.
19. Thanaviratananich S., Laopaiboon M., Vatanasapt P. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media // Cochrane Database Syst. Rev. – 2008.– Vol. 8, N 4. – CD004975.
20. Craig W.A. Antimicrobial resistance issues of the future // Diagn. Microbiol. Infect. Dis. – 1996. – Vol. 25, N 4. – P. 213–217.
21. Jacobs M.R. Building in efficacy: developing solutions to combat drug–resistant S. pneumonia // Clin. Microbiol. Infect. – 2004. – Vol. 10, Suppl. 2 – P. 18–27.
22. Fonseca W., Hoppu K., Rey L.C. et al. Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia // Antimicrob. Agents. Chemother. – 2003. – Vol. 47, N 3. – P. 997–1001.
23. Verrue C., Mehuys E., Boussery K. et al. Tablet–splitting: a common yet not so innocent practice // J. Adv. Nurs. – 2011. – Vol. 67, N 1. – P. 26–32.
24. Tu Y.H., Stiles M.L., Allen L.V. Jr et al. Stability of amoxicillin trihydrate–potassium clavulanate in original containers and unit dose oral syringes // Am. J. Hosp. Pharm. – 1988. – Vol. 45, N 5. – P. 1092–1099.
25. Mehta A.C., Hart–Davies S., Payne J., Lacey R.W. Stability of amoxycillin and potassium clavulanate in co–amoxiclav oral suspension // J. Clin. Pharm. Ther. – 1994. – Vol. 19, N 5. – P. 313–315.